174 results on '"Bicker, Joana"'
Search Results
2. Aging and cognitive resilience: Molecular mechanisms as new potential therapeutic targets
3. Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics
4. Unveiling the potential of intranasal delivery of renin-angiotensin system drugs: Insights on the pharmacokinetics of irbesartan
5. Effect of bioactive extracts from Eucalyptus globulus leaves in experimental models of Alzheimer’s disease
6. Blood brain barrier dysfunction in healthy aging and dementia: Why, how, what for?
7. Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
8. Intranasal delivery of paroxetine: A preclinical study on pharmacokinetics, depressive-like behaviour, and neurochemical sex differences
9. Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression
10. Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability
11. Under the umbrella of depression and Alzheimer’s disease physiopathology: can cannabinoids be a dual-pleiotropic therapy?
12. HPLC method for the determination of antiepileptic drugs in human saliva and its application in therapeutic drug monitoring
13. Development and application of an HPLC-DAD technique for human plasma concentration monitoring of perampanel and lamotrigine in drug-resistant epileptic patients
14. Development and validation of an HPLC-DAD method for the quantification of cannabigerol, cannabidiol, cannabinol and cannabichromene in human plasma and mouse matrices.
15. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma
16. Intranasal administration of sertraline ensures sustained brain delivery and antidepressant effect in a mouse model of depression
17. Liquid chromatographic methods for the determination of direct oral anticoagulant drugs in biological samples: A critical review
18. Antidepressants and nose-to-brain delivery: drivers, restraints, opportunities and challenges
19. Novel Routes to Accessing the Brain: Intranasal Administration
20. Understanding Brain Delivery
21. Targeting Alzheimer's disease hallmarks with the Nrf2 activator Isoeugenol
22. Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
23. Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy
24. Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays
25. Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration
26. Air-liquid interface (ALI) impact on different respiratory cell cultures
27. Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment
28. A new PAMPA model using an in-house brain lipid extract for screening the blood–brain barrier permeability of drug candidates
29. Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients
30. Blood–brain barrier models and their relevance for a successful development of CNS drug delivery systems: A review
31. Clinical Application of Pharmacokinetics to Appraise Adherence to Levetiracetam in Portuguese Epileptic Patients
32. Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples—A review
33. Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and future
34. Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
35. Antidepressants and Circadian Rhythm: Exploring Their Bidirectional Interaction for the Treatment of Depression
36. Pharmacology of lacosamide: From its molecular mechanisms and pharmacokinetics to future therapeutic applications
37. Is intranasal administration an opportunity for direct brain delivery of lacosamide?
38. A combo-strategy to improve brain delivery of antiepileptic drugs: Focus on BCRP and intranasal administration
39. Repairing blood-CNS barriers: Future therapeutic approaches for neuropsychiatric disorders
40. Cystic fibrosis: Physiopathology and the latest pharmacological treatments
41. Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
42. QbD-driven development of intranasal lipid nanoparticles for depression treatment
43. Nose-to-brain Delivery of Natural Compounds for the Treatment of Central Nervous System Disorders
44. Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics
45. Corrigendum to “Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challenges” [Life Sci. 240 (2020) 117093]
46. Anti-PD-1 immunotherapy in advanced metastatic melanoma: State of the art and future challenges
47. 'The Chemistry of Allenes'
48. Nose-to-brain delivery of levetiracetam after intranasal administration to mice
49. ABC transporters in drug-resistant epilepsy: mechanisms of upregulation and therapeutic approaches
50. Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.